Publications

1. W Luman, RS Gray.

Adverse reactions associated with Sumatriptan.

Lancet 1993;341; 1091-1092. (Letter)

2. W Luman, RS Gray, WG Middleton.

Acute myelocytic leukaemia presenting as anergic pulmonary tuberculosis.

Scottish Medical Journal 1994,39;4:116-117.

3. W Luman, R Pendek, RS Gray, KR Palmer.

Prednisolone metasulphobenzoate foam retention enemas suppress hypothalamic-pituitary-adrenal axis.  Alimentary pharmacology and therapeutics 1994;8:255-258.

4. W Luman, N Hudson, CP Choudari, KR Palmer, MA Eastwood.

Distal biliary stricture as a complication of sclerosant injection for bleeding duodenal ulcer.

Gut 1994;35:1665-1667.

5. W Luman, AJK Williams, MV Merrick, MA Eastwood.

Idiopathic bile acid malabsorption - long term outcome.

European Journal of Gastroenterology and Hepatology 1995,7:641-645.

6. CP Choudari , W Luman,  MA Eastwood, KR Palmer.

Bleeding duodenal diverticulum.

Endoscopy 1995;27:284.

7. W Luman, AM Alkout, CC Blackwell, DM Weir, KR Palmer.

Helicobacter pylori in the mouth - negative isolation from dental plaque and saliva.

European Journal of Gastroenterology and Hepatology 1996, 8:11-14.

8. W Luman, A Lessels, KR Palmer.

Failure of Nd-YAG photocoagulation therapy as treatment for Barrett's oesophagus- a pilot study.

European Journal of Gastroenterology and Hepatology 1996, 8:627-630.

9. W Luman, WH Adams, KR Palmer, SJ Nixon, IM Macintyre, G Wilson, D Hamer-Hodges.

The post laparoscopic cholecystectomy syndrome - a prospective study.

Gut 1996; 39:863-866.

10. W Luman, AJK Williams, A Pryde, GD Smith, SJ Nixon, RC Heading, KR Palmer.

The effect of cholecystectomy upon sphincter of Oddi motility.

Gut 1997; 41:371-374.

11. W Luman, A Pryde, GD Smith, RC Heading, KR Palmer.

Effect of topical glyceryltrinitrate upon sphincter of Oddi motility.

Gut 1997; 40:541-543.

12. AM Alkout, CC Blackwell, DM Weir, IR Poxton, RA Elton, W Luman, KR Palmer.

Isolation of a cell surface component of a Helicobacter pylori that binds H type 2 Lewis^a and Lewis^b blood group antigens.

Gastroenterology 1997; 112:1179-1187.

13. W Luman, A Cull, KR Palmer.

Quality of life in patients stented for malignant biliary obstructions.

European Journal of Gastroenterology and Hepatology 1997; 9:481-484.

14. W Luman, JEF Ardill, E Armstrong, GD Smith, L Brett, AM Lessells,WG Haynes, DJ Webb, KR Palmer.

Nitric oxide and gallbladder motor function.

Alimentary Pharmacology and Therapeutics 1998; 12: 425-432.

 

15. W Luman, S Ghosh, KR Palmer.

A combination of ciprofloxacin and Rowachol does not prevent biliary stent occlusion.

Gastrointest Endosc. 1999 Mar;49(3 Pt 1):316-21.

16. W Luman, KL Ling, HS Ng.

One week triple therapy for Helicobacter pylori associated duodenal ulcer disease.

Singapore Medical Journal 1999; 40(12): 738-741.

17. W Luman, KB Chua, WK Cheong, Ng HS.

Gastrointestinal manifestations of systemic lupus erythematosus.

Singapore Medical Journal 2001;42:380-384

18. W Luman, Ng HS

Survey of dyspepsia management in community.

Singapore Medical Journal 2001; 42(1):26-29.

19. W Luman, Kwek KR, Loi KL, M Chiam, Cheung WK.

Percutaneous endoscopic gastrostomy – indications and outcome of our experience at the Singapore General Hospital.

Singapore Medical Journal 2001; 42(10):460-465.

20. KL Ling, W Luman, B Ho, HS Ng

Efficacy of a nitroimidazole containing triple therapy regime in Singapore.

Singapore Medical Journal 2001;42(7): 317-321.

21. W Luman, Zhao Yi, Ng HS, Ling KL

Helicobacter Pylori infection is unlikely to be transmitted between partners: evidence from genotypic study in partners of infected patients.

European Journal of Gastroenterology and Hepatology 2002;14 (5): 521-528.

22. W Luman, JL Shaffer.

Prevalence, outcome and associated factors of deranged liver function tests in patients on home parenteral nutrition.

Clin Nutr. 2002 Aug;21(4):337-343.

23. W Luman, ES-Y Chan.

Mathematical model for predicting therapeutic ERCP.

Digestive and Liver Disease 2003:35:486-492.

24. GD Smith, R Watson, D Roger, E McRorie, N Hurst, W Luman, KR Palmer

Impact of a nurse-led counselling service on quality of life in patients with inflammatory bowel disease.

Journal of Advanced Nursing 2002; 38(2): 152-160.

25. Ng KL, Ng HS, W Luman.

Gastrointestinal manifestations of cytomegalovirus infection in non-HIV infected patients.  Medical Journal of Malaysia 2003: 58(3); 337-344.

26. W Luman, Zhao Yi, Ng HS, Ling KL

Genotypic study of Helicobacter pylori in partners of infected patients.

SGH Proceedings 2002; 11: 4-12.

27. Ling KL, Ooi CJ, Luman W, Cheong WK, Choen FS, Ng HS.

Clinical characteristics of ulcerative colitis in Singapore, a multiracial city-state.

J Clin Gastroenterol. 2002 Aug;35(2):144-8.

28. W Luman, Ng KL.

Audit of investigations in patients with iron deficiency anaemia.

SMJ 2003; 44(10): 504-510.

29. Chan SL, W Luman

Appropriateness of parenteral nutrition use in a tertiary-care hospital.

Ann of Acad Med Singapore 2004; 33:494-8.

30. A B E Kwek, E K Tan , W Luman.

Dysphagia as a side effect of botulinum toxin injection – A Case Report.

Medical Journal of Malaysia 2004; 59:544-546.

31. Kelvin Teck Joo Thia, Widjaja Luman, Ooi Choon Jin.

Crohn’s disease runs a more aggressive course in young Asian patients.

Inflamm Bowel Dis 2006; 12(1):57-61.

32. Priyanthi MK,  Lim TKH, Ooi CJ, W Luman, Tan SY, Koh M.

Tubule neck dysplasia: precursor lesion of signet cell carcinoma and the immunohistochemical profile

Pathology 2006; 38 (5): 468-471.

33. W Luman

Patient’s perception on transnasal gastroscopy.

SMJ 2008; 49(4):339-341)

34. Crohn's disease runs a more aggressive course in young Asian patients.

Thia KT, Luman W, Jin OC.

Inflamm Bowel Dis. 2006 Jan;12(1):57-61.

35. Early experience with double balloon enteroscopy: a leap forward for the gastroenterologist.

Ang D,  Luman W, Ooi CJ.

Singapore Med J. 2007 Jan;48(1):50-60.

36. Endoscopic biopsy features and diagnostic challenges of adult Crohn's disease at initial presentation.

Kumarasinghe MP, Quek TP, Chau CY, Mustapha NR, Luman W, Ooi CJ.

Pathology. 2010 Feb;42(2):131-7.

37. Boceprevir early-access for advanced-fibrosis/cirrhosis in Asia-Pacific hepatitis C virus genotype 1 non-responders/relapsers.

Sukeepaisarnjaroen W, Pham T, Tanwandee T, Nazareth S, Galhenage S, Mollison L, Totten L, Wigg A, Altus R, Colman A, Morales B, Mason S, Jones T, Leembruggen N, Fragomelli V, Sendall C, Guan R, Sutedja D, Tan SS, Dan YY, Lee YM, Luman W, Teo EK, Than YM, Piratvisuth T, Lim SG.

World J Gastroenterol. 2015 Jul 28;21(28):8660-9.